Lorenzo Guizzaro,Spyridon Drosos,Ulrik Kihlbom et al.
Lorenzo Guizzaro et al.
Medicines, including those intended for the treatment of cancer, are tightly regulated. Such regulation, historically linked to disasters due to unsafe medicines, evolved to cover all aspects of research around the quality, safety and effic...
Florian Steger,Maximilian Schochow
Florian Steger
Among the primary function of the media are conveying personal understanding and expanding the subjective knowledge of the recipient citizen. A particular challenge arising during this process is the mediation of medical knowledge. In addit...
Bernt-Peter Robra
Bernt-Peter Robra
In recommending and offering screening, health services make a health claim ('it's good for you'). This article considers ethical aspects of establishing the case for cancer screening, building a service programme, monitoring its operation,...
The Right to Know and not to Know: Predictive Genetic Diagnosis and Non-diagnosis [0.03%]
知与不知的权利——预测性遗传诊断及非诊断
Gunnar Duttge
Gunnar Duttge
The expansion of genetic diagnostic potential in the direction of future contingencies (risks) creates temptations and compulsions for timely knowledge and responsible-sometimes radical-prevention. In the area of mamma carcinoma, the 'Angel...
Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks [0.03%]
风险调整下的预防。遗传（乳腺癌）风险福利权益治理的视角分析
Friedhelm Meier,Anke Harney,Kerstin Rhiem et al.
Friedhelm Meier et al.
This article is a revised version of our proposal for the establishment of the legal concept of risk-adjusted prevention in the German healthcare system to regulate access to risk-reduction measures for persons at high and moderate genetic ...
Wilhelm G Dirks
Wilhelm G Dirks
Human and animal cell cultures are indispensable model systems for the biomedical research and pharmaceutical industry and already represent one of the most important alternatives to animal experiments. The development of mammalian cell cul...
Marium Salwa,Tarek Abdullah Al-Munim
Marium Salwa
Human papillomavirus (HPV) vaccination of young adolescent girls as a part of primary prevention of cervical cancer is now a routine practice in many countries. Bangladesh, a lower-middle income country, observed a successful HPV vaccinatio...
One in Four Dies of Cancer. Questions About the Epidemiology of Malignant Tumours [0.03%]
四分之一的癌症患者死亡。恶性肿瘤流行病学问题不容忽视
Christel Weiss
Christel Weiss
Cancer is the second leading cause of death globally. Malignant tumours are responsible for about 9.6 million deaths in 2018 (Ritchie H (2019) How many people in the world die from cancer? https://ourworldindata.org/how-many-people-in-the-w...
'The King of Diseases': An Essay on the Special Attention Paid to Cancer Patients and How It Came About [0.03%]
《万病之王》：癌症患者的特殊待遇及其来由述评
Wolfgang U Eckart
Wolfgang U Eckart
The history of cancer during the twentieth century demonstrates that various factors have contributed to the perception of cancer as the 'Emperor of All Maladies', although this has never been true from an epidemiological perspective. Depen...
Wei-Liang Shih,Chi-Tai Fang,Pei-Jer Chen
Wei-Liang Shih
Hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), Epstein-Barr virus (EBV), human T-cell lymphotropic virus type 1 (HTLV-1), Kaposi's sarcoma-associated herpesvirus (KSHV), and Merkel cell polyomavirus (MCV) con...